The annotation files of Tibetan black bear (Ursus thibetanus thibetanus) draft genome

Tibetan black bear genome annotation file (gff3 format)Tibetanblackbear.gff.gzThe predicted protein sequences of the annotations for the genome of Tibetan black bear (fasta format)Tibetanblackbear.pep.fasta.gzThe predicted protein-codng sequences of the annotations for the genome of Tibetan black bear (fasta format)Tibetanblackbear.cds.fasta.gz</div

The annotation files for the draft genome of the Tibetan black bear (Ursus thibetanus thibetanus)

Tibetan black bear genome annotation file (gff3 format)Tibetanblackbear.gff.gzThe predicted protein sequences of the annotations for the genome of Tibetan black bear (fasta format)Tibetanblackbear.pep.fasta.gzThe predicted protein-codng sequences of the annotations for the genome of Tibetan black bear (fasta format)Tibetanblackbear.cds.fasta.gz</div

Quality characteristics for samples by timepoint.

Quality characteristics for samples by timepoint.</p

Data_Sheet_1_Draft Genome Assembly for the Tibetan Black Bear (Ursus thibetanus thibetanus).docx

The full text of this article can be freely accessed on the publisher's website

Overall gene alterations from swab acquired tumor samples (patients 2–30) is similar to landscape of TCGA cervical squamous cell carcinoma dataset.

(A) Ninety-four percent (1339/1430) of altered genes in baseline samples (defined as substitutions, insertions or deletions in gene) were also identified in the TCGA dataset, suggesting accurate identification of mutated genes related to cervical cancer. (B) The distribution of the top 30 most altered genes in study samples 2–30 and in TCGA(C) was also similar. (TIF)</p

Sample and sequencing quality control metrics and tumor purity estimates for each tumor sample.

(XLSX)</p

Fig 3 -

Quality Characteristics and DNA alterations for all Samples by Time (A) Total DNA yield did not differ by acquisition timepoint. Total reads (B), mean target coverage (C) and mapping rate (D) did not differ by timepoint. Number of DNA alterations at baseline decreased at week 5 of CRT in all patients (E, p = 0.008) as well as when 33 patients with samples at all 4 time points were examined (F, p = 0.03).</p

Overall study design and CONSORT diagram.

(A) Patients with cervical cancer underwent five weeks of external beam radiation therapy (EBRT) followed by two brachytherapy treatments (B1 and B2), with swab samples collected at baseline, week 1, week 3, and week 5 of radiation therapy as well as week 12 (after completion of radiation therapy). (B) Of the 73 patients accrued on protocol, 70 patients with 217 total samples had DNA of adequate quantity and quality for sequencing. One tumor sample failed sequencing due to low quantity and high degradation and was not included in the analysis.</p

Patient characteristics.

Patient characteristics.</p

Gene list with alteration type and frequency for all samples.

(CSV)</p